| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8690397 | Pediatric Neurology | 2018 | 6 Pages |
Abstract
Dimethyl fumarate treatment was associated with a reduction in magnetic resonance imaging activity in pediatric patients; pharmacokinetic and safety profiles were consistent with those in adults. Dimethyl fumarate is a potential treatment for pediatric multiple sclerosis.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Raed Alroughani, Rajiv Das, Natasha Penner, Joe Pultz, Catherine Taylor, Satish Eraly,